A comprehensive view of Health Canada. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Health Canada approves TiO2 as safe for use as a food additive, noting that EU conclusions on its toxicity were based on studies using TiO2 that was not food-grade

Health Canada issues notice of compliance for Bristol Myers Squibb Canada’s Opdivo injectable as a monotherapy for adjuvant treatment for urothelial carcinoma; drug is first adjuvant Immunotherapy for patients at high risk of disease recurrence

Health Canada approves Novartis’ Tabrecta capmatinib tablets to treat adults with locally advanced unresectable or metastatic non-small cell lung cancer; NSCLC is most common type of lung cancer, will affect 30,000 Canadians in 2022

Bausch + Lomb receive Health Canada approval for Lumify brimonidine tartrate ophthalmic solution 0.025% w/v OTC eye drop to relieve eye redness; product available in 3.5 mL and 7.5 mL sizes, is first OTC eye drop of its kind in Canada

Canada experiencing a shortage of baby-formula made for infants with food allergies and some medical conditions, says Health Canada, adding that the shortage is due to the closure of Abbott Laboratories' manufacturing plant in the US

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count